Louis Levine, MD, MEd
DownloadHi-Res Photo
Cards
Training
RESIDENCY
Yale New Haven Hospital (2023)
Yale New Haven Hospital (2023)
MD
Penn State College of Medicine (2020)
Penn State College of Medicine (2020)
About
Titles
Clinical Fellow
Biography
I am a Clinical Gastroenterology & Hepatology Fellow in the Section of Digestive Diseases at Yale School of Medicine. My clinical and research interests are in general gastroenterology, inflammatory bowel diseases (Crohn's disease and ulcerative colitis), and medical education. I am a Connecticut native, and prior to fellowship, I completed Internal Medicine residency at Yale. While in medical school at Penn State, I served as President of my class and earned a Master's Degree in Adult Education during my final year. Outside of the hospital, I enjoy cooking and eating, competing in local pickleball tournaments, trivia, and watching TV and movies.
Education & Training
- RESIDENCY
- Yale New Haven Hospital (2023)
- MD
- Penn State College of Medicine (2020)
- MEd
- Penn State University, Adult Education (2020)
- BS
- Cornell University, Nutritional Sciences & Health Policy (2016)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Louis Levine's published research.
Publications Timeline
A big-picture view of Louis Levine's research output by year.
Badr Al Bawardy, MD
Deborah Proctor, MD
Jill Gaidos, MD
2Publications
10Citations
Publications
2023
Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis
Sharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis. Crohn's & Colitis 360 2023, 5: otad032. PMID: 37323477, PMCID: PMC10263117, DOI: 10.1093/crocol/otad032.Peer-Reviewed Original ResearchCitationsAltmetricConceptsAcute severe ulcerative colitisSevere ulcerative colitisClinical outcomesSigmoidoscopy groupHospital stayFlexible sigmoidoscopyUlcerative colitisIntravenous corticosteroid useRate of colectomyRisk of colectomyHours of admissionOpioid medication useShorter hospital stayCohort of patientsFavorable clinical outcomeLarge prospective studiesRelevant clinical outcomesColectomy rateCorticosteroid useSecondary outcomesMedication usePrimary outcomeProspective studyRetrospective studySigmoidoscopy
2022
Effect of obesity on vedolizumab response in inflammatory bowel disease
Levine LJ, Gaidos JKJ, Proctor DD, Viana AV, Al-Bawardy B. Effect of obesity on vedolizumab response in inflammatory bowel disease. Annals Of Gastroenterology 2022, 35: 275-280. PMID: 35599926, PMCID: PMC9062841, DOI: 10.20524/aog.2022.0699.Peer-Reviewed Original ResearchCitationsAltmetricConceptsBody mass indexInflammatory bowel diseaseSteroid-free clinical remissionNon-obese groupC-reactive proteinObese groupCRP normalizationEndoscopic remissionIBD patientsBowel diseaseDose escalationNormal serum C-reactive proteinMedian body mass indexSerum C-reactive proteinHigher body mass indexEndoscopic remission ratesEffect of obesityVedolizumab discontinuationVedolizumab levelsClinical remissionMedian followRemission rateSecondary outcomesMedian agePrimary outcome
Links & Media
News
- September 19, 2023
Welcome New Postdocs, Postgrads, and Clinical Fellows in the Section of Digestive Diseases (September 2023)
- August 16, 2023
Welcome New Postdocs, Postgrads, Fellows, Faculty & Staff! (August 2023)
- August 10, 2023
Ulcerative Colitis: Early Sigmoidoscopy & Clinical Outcomes (Discoveries & Impact August 2023)
- October 08, 2020
Resident Roundup: Louis Levine